Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia (Q66342317)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
clinical trial

    Statements

    title
    Renvela® Post-Marketing Observational Study to Monitor the Clinical Use in Adult Hyperphosphataemic Chronic Kidney Disease Patients Not On Dialysis With Serum Phosphorus ≥1.78 mmol/L (English)
    0 references
    country
    Austria
    0 references
    Denmark
    0 references
    France
    0 references
    Germany
    0 references
    Italy
    0 references
    Netherlands
    0 references
    Spain
    0 references
    start time
    September 2010
    0 references
    end time
    October 2012
    0 references
    number of participants
    210
    0 references
    minimum age
    18 year
    0 references
    maximum age
    65 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q66342317&oldid=2237170483"